---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-039783"
form_type: "8-K"
ticker: "AQST"
cik: "0001398733"
company_name: "Aquestive Therapeutics, Inc."
filed_at: "2024-09-09T23:59:59+00:00"
generated_at: "2026-05-31T05:52:25.863152+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Aquestive Therapeutics furnishes investor presentations; no material new disclosures

## Summary
- Filed Form 8-K on September 9, 2024 to disclose investor presentation and H.C. Wainwright conference slides.
- Presentations provided as Exhibit 99.1 and 99.2; no specific financial updates or guidance changes were included in the filing.
- Information is furnished under Regulation FD and not deemed filed for SEC liability purposes.
- No material new business developments, earnings data, or strategic actions were reported.

## SEC filing metadata
- accession: 0001628280-24-039783
- form_type: 8-K
- ticker: AQST
- cik: 0001398733
- company_name: Aquestive Therapeutics, Inc.
- filed_at: 2024-09-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1398733/000162828024039783/0001628280-24-039783-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1398733/000162828024039783/aqst-20240909.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-039783
- JSON: https://secwatch.observer/filing/0001628280-24-039783.json
- Plain text: https://secwatch.observer/filing/0001628280-24-039783.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.